Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $44.1000 (3.76%) ($42.2000 - $44.1000) on Fri. Jul. 25, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.7% (three month average) | RSI | 54 | Latest Price | $44.1000(3.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) IWM(7%) JNK(7%) PEJ(7%) VT(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.35% in a week (0% probabilities). VIXM(-5%) TLT(-4%) UUP(-2%) GLD(-2%) SLV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.35% (StdDev 4.7%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
5 Day Moving Average | $41.32(6.73%) | 10 Day Moving Average | $41.06(7.4%) | 20 Day Moving Average | $41.52(6.21%) | To recent high | -34.7% | To recent low | 11.6% | Market Cap | $869m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |